EAHP 2012 Report – An Irish Viewpoint
by Zara Qadir – Some quotes from Irish Pharmacists at EAHP 2012.
by Zara Qadir – Some quotes from Irish Pharmacists at EAHP 2012.
by Christine Clark – Changes in the diagnosis and treatment of cancer form the basis for future developments. There have been many revolutions in medical science over the… read more.
by Zara Qadir – Even with international guidelines for pain treatment, therapy has to be individualised for patients and pharmacists can play an important role in the management… read more.
by Zara Qadir – Five years of evolution in Hospital Pharmacy. The 40th EAHP meeting provided an opportunity for Tajda Miharija-Gala and Juraj Sykora, Directors of Professional Development,… read more.
by Zara Qadir reporting on the presentation by Yechiel Hekster (pictured), Professor of Clinical Pharmacy, and a member of The Netherlands Medicines Evaluation Board.
Zara Qadir interviews Dr Chantal Bélorgey (pictured), Head of Clinical Trial Development at the French national competent authority, Affsaps (Agence française de sécurité sanitaire des produits).
by Bruce Sylvester – taken from the British Medical Journal (BMJ) Long-term opium use almost doubles the risk of death from many causes, particularly circulatory diseases, respiratory conditions,… read more.
The antidepressant duloxetine (Cymbalta ®) can effectively treat chemotherapy-induced neuropathy in some patients , researchers reported on July 3, 2012 at the American Society of Clinical Oncology Annual… read more.
Researchers identify new therapeutic target for pancreas’ dangerous, sudden swelling and inflammation.
by Thomas R. Collins – With a scarcity of livers available for transplantation, there is a tremendous pressure on the medical community to make the best use of… read more.
Mood and anxiety disorders such as bipolar, panic disorder and major depressive disorder appear to be highly associated with non-medical prescription opioid use.
by Bruce Sylvester – Women with breast pain who undergo extra-routine mammograms, MRIs or ultrasounds as part of breast pain evaluation derive no diagnostic or therapeutic benefit, researchers… read more.